Expert Interview
A second opinion: Examining the benefits of Abbott's TriClip device compared to medical therapy for tricuspid regurgitation
Ticker(s): ABT, EWInstitution: The University of Tennessee College of Medicine
- Assistant Professor at the University of Tennessee College of Medicine, Co-Director of complex coronary intervention & Chairs the Interventional Cardiology Chronic Total Occlusion Affinity Group at Ascension Saint Thomas Hospital.
- Has treated ~30 patients with mitral regurgitation using MitraClip.
- Clinical and research focus on the management of complex coronary disease, including chronic total occlusions, imaging, physiology, peripheral arterial revascularization, cardiogenic shock, and management of pulmonary embolism.
Please describe your background and patient setting.
Added By: ben_adminHow many patients with tricuspid regurgitation do you manage?
Added By: ben_adminWhat is the current standard of care for tricuspid regurgitation?
Added By: ben_adminHow many patients have you referred for Abbott's TriClip device?
Added By: ben_adminWhat is your opinion on the data from the Triluminate study?
Added By: ben_adminDo you think the use of Abbotts TriClip will increase or decrease because of this data?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
